Particle.news

Download on the App Store

Brain Neurons Found to Drive Type 2 Diabetes, Independent of Obesity

New research highlights hyperactive hypothalamic AgRP neurons as a key driver of diabetes, reframing the disease as a neurocircuitry disorder and opening pathways for brain-targeted therapies.

Image
He noted, for instance, that Ozempic and other new drugs used to treat type 2 diabetes are also able to inhibit AgRP neurons. Credit: Neuroscience News
Image

Overview

  • Scientists discovered that silencing hyperactive AgRP neurons in diabetic mice normalized blood sugar for months without affecting weight or food intake.
  • This challenges long-held beliefs linking type 2 diabetes primarily to obesity and insulin resistance, shifting focus to brain neurocircuitry.
  • The study used a viral genetics approach to block communication between AgRP neurons, revealing their critical role in glucose regulation.
  • Existing diabetes drugs, like GLP-1 receptor agonists, may partially work by inhibiting these neurons, though further research is needed to confirm this mechanism.
  • Researchers aim to translate these findings into human trials and explore safe methods to modulate AgRP neuron activity for therapeutic purposes.